Jyong Biotech Ltd. Additional Paid in Capital, Common Stock
Jyong Biotech Ltd. (MENS) had Additional Paid in Capital, Common Stock of $28.53 million as of 2025-12-31, per its 20-F filed 2026-05-15.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapitalCommonStock · last filed 2026-05-15
- 2025-12-31: Additional Paid in Capital, Common Stock $28.53M.
- 2024-12-31: Additional Paid in Capital, Common Stock $11.80M.
| Period end | Additional Paid in Capital, Common Stock |
|---|---|
| 2025-12-31 | $28.53M 20-F · filed 2026-05-15 |
| 2024-12-31 | $11.80M 20-F · filed 2026-05-15 |